Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUMO study of luteal phase progesterone support in MOH-IUI
NL-OMON60202Phase 4Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of progesterone in Unexplained infertility and hypofertility (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Cumulative live birth within 6 months. Started Mar 2023; status: active, not recruiting.
02
Drugs
progesterone
03
Conditions
Unexplained infertilityhypofertility
Beyond the preview
Go deeper on NL-OMON60202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60202.